...
首页> 外文期刊>Surgical laparoscopy, endoscopy and percutaneous techniques >Prognostic Factors of Oral Intake After Endoscopic Gastroduodenal Stent Placement for Advanced Gastric Cancer
【24h】

Prognostic Factors of Oral Intake After Endoscopic Gastroduodenal Stent Placement for Advanced Gastric Cancer

机译:胃镜十二指肠内支架置入治疗晚期胃癌后口服摄入的预后因素

获取原文
获取原文并翻译 | 示例

摘要

Gastroduodenal stents are effective for gastric outlet obstruction (GOO) due to gastric cancer. However, some patients are unable to eat again soon. We retrospectively analyzed the cause of short-feeding periods. Between 2011 and 2015, we performed stent placement in 22 patients who could not eat solids. The effects of clinical characteristics on duration of oral intake were analyzed using Cox proportional hazards models. Univariate analyses revealed that the degree of GOO [no oral intake/liquids only; hazard ratio (HR), 10.9; 95% confidence interval (CI), 2.5-48.1; P=0.003], performance status score (2 or 3/0 or 1; HR, 5.7; 95% CI, 1.8-16.9; P=0.004), and poststenting chemotherapy (no/yes; HR, 5.7; 95% CI, 1.9-18.9; P=0.002) were significant factors for cessation of oral intake. Multivariate analysis showed that GOO and chemotherapy were significant factors. Gastroduodenal stents were less effective for patients with severe stenosis or without poststenting chemotherapy.
机译:胃十二指肠支架可有效治疗由于胃癌引起的胃出口梗阻(GOO)。但是,有些患者无法尽快再次进食。我们回顾性分析了进食不足的原因。在2011年至2015年之间,我们对22名无法吃固体的患者进行了支架置入。使用Cox比例风险模型分析临床特征对口服时间的影响。单因素分析表明,GOO的程度[仅口服/不口服;危险比(HR)为10.9; 95%置信区间(CI)为2.5-48.1; P = 0.003],表现状态评分(2或3/0或1; HR,5.7; 95%CI,1.8-16.9; P = 0.004)和放化疗后(否/是; HR,5.7; 95%CI, 1.9-18.9; P = 0.002)是停止口服的重要因素。多因素分析表明,GOO和化疗是重要因素。胃十二指肠支架对于严重狭窄或未进行支架后化疗的患者效果较差。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号